combination therapy

Open Access
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, NATHANIEL F. WU, JUN YAMAMOTO, KAZUYUKI HAMADA, QINGHONG HAN, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research April 2021, 41 (4) 1745-1751; DOI: https://doi.org/10.21873/anticanres.14939
You have access
Anti-leukemic Activity of AIU2008 in FLT3-ITD-positive Acute Myeloid Leukemia
HYO JEONG KIM, HWANI RYU, HYUN-KYUNG CHOI, JIE-YOUNG SONG, SANG-GU HWANG and JIYEON AHN

Anticancer Research February 2021, 41 (2) 731-737; DOI: https://doi.org/10.21873/anticanres.14824
You have access
Brucea javanica Increases Survival and Enhances Gemcitabine Efficacy in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Pancreatic Cancer
HAITAO YANG, ZHONG TONG, LEI SHEN, YU SUN, ROBERT M. HOFFMAN and JUN HUANG

Anticancer Research September 2020, 40 (9) 4969-4978; DOI: https://doi.org/10.21873/anticanres.14500
You have access
Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells
EDGAR HEINZ UWE WENDT, MARIA SCHOENROGGE, BRIGITTE VOLLMAR and DIETMAR ZECHNER

Anticancer Research January 2020, 40 (1) 153-160; DOI: https://doi.org/10.21873/anticanres.13936
You have access
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse Model
GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, BRYAN CLARY, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN

Anticancer Research December 2019, 39 (12) 6463-6470; DOI: https://doi.org/10.21873/anticanres.13860
You have access
Combination of Trabectedin With Oxaliplatinum and 5-Fluorouracil Arrests a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse Model
GUANGWEI ZHU, MING ZHAO, QINGHONG HAN, YUYING TAN, YU SUN, MICHAEL BOUVET, SHREE RAM SINGH, JIANXIN YE and ROBERT M. HOFFMAN

Anticancer Research November 2019, 39 (11) 5999-6005; DOI: https://doi.org/10.21873/anticanres.13805
You have access
Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
TAKASHI HIGUCHI, NORIHIKO SUGISAWA, KENTARO MIYAKE, HIROMICHI OSHIRO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, ZOEY KLINE, PAIGE BELT, SANT P. CHAWLA, MICHAEL BOUVET, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4781-4786; DOI: https://doi.org/10.21873/anticanres.13662
You have access
Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model
TAKASHI HIGUCHI, NORIHIKO SUGISAWA, KENTARO MIYAKE, HIROMICHI OSHIRO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, SANT P. CHAWLA, MICHAEL BOUVET, SHREE RAM SINGH, HIROYUKI TSUCHIYA and ROBERT M. HOFFMAN

Anticancer Research August 2019, 39 (8) 4079-4084; DOI: https://doi.org/10.21873/anticanres.13565
You have access
Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade
DAIKO WAKITA, TOSHIKI IWAI, SUGURU HARADA, MIHO SUZUKI, KANAME YAMAMOTO and MASAMICHI SUGIMOTO

Anticancer Research April 2019, 39 (4) 1749-1760; DOI: https://doi.org/10.21873/anticanres.13281
You have access
Coupling Dichloroacetate Treatment with Curcumin Significantly Enhances Anticancer Potential
PING-CHUAN KAN, YU-JIA CHANG, CHIN-SUNG CHIEN, CHEN-YING SU and HSU-WEI FANG

Anticancer Research November 2018, 38 (11) 6253-6261; DOI: https://doi.org/10.21873/anticanres.12981

Main menu

User menu

Search

combination therapy

Pages